How is GenAI making healthcare personalized, predictive and preventive

Related topics

In this episode, Ankur Dhandharia, Partner, EY-Parthenon India, shares how Generative AI is emerging as a key frontier in healthcare innovation. He highlights how GenAI is helping make healthcare more personalized, predictive and preventive, and explains why it represents both an opportunity and a responsibility to build a healthier future for India.

Key takeaways

Personalized care: GenAI is accelerating the diagnosis of complex and rare diseases, enabling faster and more tailored treatment plans.
Preventive healthcare: By extending diagnostic capabilities to rural India, GenAI is improving the early detection of critical illnesses like lung and breast cancer.
Predictive insights: With increasing healthcare data, GenAI is helping analyse patterns to anticipate diseases, reduce strain on the healthcare system, and improve outcomes.

For your convenience, a full text transcript of this podcast is available on the link below:

Ankur

Hello, everyone. My name is Ankur Dhandharia. I am a Partner with the EY-Parthenon practice, focusing on healthcare strategy.
Today, I am here today to talk about a topic that is very close to my heart, that is how GenAI is the next frontier in healthcare innovation. I will talk about three things: how GenAI is making healthcare personalized, predictive and preventive.
On the personalized side, GenAI and AI in GenAI are helping diagnose diseases, rare genetic disorders in days, which used to take months and weeks earlier. It is a fantastic thing today— making personalized health care possible.
On the preventive side, GenAI is making healthcare accessible to places like rural India, where specialists are not available today. (It is doing so) by making available diagnostic tools for early identification of diseases like lung and breast cancer.
Again, on the predictive side, with more and more healthcare data being available, GenAI and AI are helping analyze data to identify and predict diseases. Hence, in a way, reducing the burden on our healthcare system.
To conclude, I would like to say that GenAI is not just an option today, it is a responsibility— to make a better and healthier future available to all Indians.

Presenters

Ankur Dhandharia,
Partner, Healthcare Strategy, EY Parthenon India

If you would like to listen to our podcasts on the go:

Spotify

SoundCloud

Podcast

Episode 26

Duration

2m 5s

In this series

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.